🔓 Unlock the full profile of Suma Krishnan (Krystal Biotech, Inc.), including verified contact details, financial insights, and professional associations.
See Suma Krishnan Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: sum*****@kry******.com
Mobile: 69715*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Suma Krishnan is the Founder and President of Krystal Biotech, Inc., a role held since April 1, 2016.
- Under Suma's leadership, Krystal Biotech focuses on developing innovative gene therapies for patients with rare diseases, significantly impacting the biotechnology industry.
- Krystal Biotech, Inc. was founded in 2016 and is publicly traded on Nasdaq under the symbol KRYS, with a current market cap of approximately $4.0 billion.
- The organization has demonstrated significant growth, with a 30.5% increase in headcount over the past 24 months, indicating robust expansion and future potential.
- Suma previously served as Chief Executive Officer of LIGHT MATTERS FOUNDATION starting in January 2011, showcasing a commitment to health-related initiatives.
- Prior to founding Krystal Biotech, Suma held the position of Senior Vice President at Intrexon Corporation within the Human Health and Therapeutic Division from 2012 to March 2016, gaining extensive industry experience.
- Additionally, Suma served as Senior Vice President at New River Pharmaceuticals from April 2002 until June 2007, contributing to the development of pharmaceutical products and strategic initiatives.
- Through these roles, Suma has navigated numerous challenges in the biotechnology sector, continuously pushing the boundaries of therapeutic solutions and patient care.